Skip Navigation
Click Subscribe to join the NIH Calendar of Events e-mail list or Sign In to add or modify your events.  

Event Details

    E-mail this page E-mail this page

Event Type:  Seminar (This is an NIH Science event)
Title:  A Potent Glycomimetic Antagonist (GMI-1271) of E-selectin in Phase 2 Clinical Trials for the Treatment of Acute Myelogenous Leukemia
Description:  GlycoMimetics is a clinical-stage biotechnology company located in Rockville, Maryland. Their drug candidate, GMI-1271, an E-selectin antagonist, is being evaluated in an ongoing Phase 1/2 clinical trial as a potential treatment for AML and in a Phase 1 clinical trial in multiple myeloma.
Series Name:  Glycobiology SIG Seminar Series
Videocast:  Event will not be videocast
Special Instructions:  To arrange sign language interpretation for an event go to the Office
of Research Services (ORS) Interpreting Service Requests web page.

Tuesday, July 11, 2017   1:00pm - 2:00pm Add To Outlook Calendar     Add To iCal Calendar     Add To Entourage Calendar
  Click on MS Outlook Calendar Icon (MS Outlook) or Mac iCal Calendar Icon (Mac iCal) or Entourage Calendar Icon (MS Entourage for MAC) to add an event into your Calendar. Need Help?

Name:   Dr. John L. Magnani
Title:   Chief Science Officer and Senior V.P.
Organization:   GlycoMimetics, Inc.
State:   Maryland

Organization(s):  [NIH] Glycobiology Interest Group

Location:  On the main NIH Campus
Building:  Building 50
Room:  Room 1227/1233

Name:   Dr. Pamela Marino
Phone:   301 594-3827
Fax:   301 480-2802
View by: Day | Week | Month | Year

Calendar Home Page | Feedback | NIH Home Page